Task: Answer the multiple-choice question.
Question: Which drug exhibits a -23.325% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) S=c1[nH]ccn1-c1cc(OCc2ccccc2)c(Cl)cc1Cl
b.) O=C(NCC1CCOCC1)c1cc(COc2cccc(C(F)(F)F)c2)on1
c.) O=C(Nc1ccc2c(c1)OCO2)c1cncc(Br)c1
d.) c1ccc(-c2nc(NCC3CCCO3)c3ccccc3n2)nc1
Answer: d. c1ccc(-c2nc(NCC3CCCO3)c3ccccc3n2)nc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(-c2nc(NCC3CCCO3)c3ccccc3n2)nc1
c1ccc(-c2nc(NCC3CCCO3)c3ccccc3n2)nc1
N-(oxolan-2-ylmethyl)-2-pyridin-2-ylquinazolin-4-amine